Abstract
Abstract
Purpose
The focus on treating patients with Menière’s Disease (MD) lies on the reduction of vertigo attacks and the preservation of sensory function. Endolympathic hydrops is considered as an epiphenomenon in MD, which can potentially be altered by endolymphatic sac surgery (ESS). Purpose of the study was to investigate the influences on vertigo control through manipulation of the perilymphatic system with or without ESS.
Methods
Retrospective data analysis of 86 consecutive patients with MD according to current diagnostic criteria after endolymphatic sac surgery alone (ESSalone; n = 45), cochlear implantation (CI) alone (CIalone; n = 12), and ESS with CI (ESS + CI; n = 29), treated at a tertiary referral center. Main Outcome Measures: vertigo control, speech perception pre- and postoperatively.
Results
Gender, side, and preoperative treatment were similar in all groups. Age was younger in the ESSalone-group with 56.2 ± 13.0 years (CIalone = 64.2 ± 11.4 years; ESS + CI = 63.1 ± 9.7 years). Definitive MD was present in all the CIalone, in 79.3% of the ESS + CI and in 59.6% of the ESSalone-patients. Likewise, vertigo control rate was 100% in the CIalone, 89.7% in the ESS + CI and 66.0% in the ESSalone-group.
Conclusions
Vertigo control was improved in all three groups, however, superior in groups treated with CI, potentially contributed by the manipulation of both the endo- and perilymphatic systems. A more systematic characterization of the patients with larger case numbers and documentation of follow up data would be needed to evaluate a clinical effect more properly.
Funder
Bundesministerium für Bildung und Forschung
Universitätsklinik München
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Otorhinolaryngology
Reference42 articles.
1. Merchant S, Adams J, Nadol JJ (2005) Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26:74–81
2. Committee on Hearing and Equilibrium (1972) Report of subcommittee on equilibrium and its measurement. Meniere’s disease: criteria for diagnosis and evaluation of therapy for reporting. Trans Am Acad Ophthalmol Otolaryngol 76(6):1462–1464
3. Pearson BW, Brackmann DE (1985) Committee on hearing and equilibrium guidelines for reporting treatment results in Meniere’s disease. Otolaryngol Head Neck Surg 93(5):579–581. https://doi.org/10.1177/019459988509300501
4. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc (1995). Otolaryngol Head Neck Surg 113 (3):181–185. doi:https://doi.org/10.1016/S0194-5998(95)70102-8
5. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandala M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A, Classification Committee of the Barany S, Japan Society for Equilibrium R, European Academy of O, Neurotology, Equilibrium Committee of the American Academy of O-H, Neck S, Korean Balance S (2015) Diagnostic criteria for Meniere’s disease. J Vestib Res 25(1):1–7. https://doi.org/10.3233/VES-150549